vs

Side-by-side financial comparison of Cheer Holding, Inc. (CHR) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.

Cheer Holding, Inc. is the larger business by last-quarter revenue ($71.0M vs $39.6M, roughly 1.8× SBC Medical Group Holdings Inc). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs 10.9%, a 25.0% gap on every dollar of revenue. On growth, Cheer Holding, Inc. posted the faster year-over-year revenue change (-0.1% vs -10.9%).

Cheer Holding, Inc. is a diversified holding company primarily operating in the Chinese market, with core business segments covering early childhood education services, mobile lifestyle platforms, digital content offerings, and integrated consumer solutions for households and enterprise partners across multiple demand scenarios.

SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.

CHR vs SBC — Head-to-Head

Bigger by revenue
CHR
CHR
1.8× larger
CHR
$71.0M
$39.6M
SBC
Growing faster (revenue YoY)
CHR
CHR
+10.8% gap
CHR
-0.1%
-10.9%
SBC
Higher net margin
SBC
SBC
25.0% more per $
SBC
35.9%
10.9%
CHR

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
CHR
CHR
SBC
SBC
Revenue
$71.0M
$39.6M
Net Profit
$7.8M
$14.2M
Gross Margin
70.7%
73.1%
Operating Margin
11.7%
32.5%
Net Margin
10.9%
35.9%
Revenue YoY
-0.1%
-10.9%
Net Profit YoY
-37.5%
117.2%
EPS (diluted)
$0.67
$0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHR
CHR
SBC
SBC
Q4 25
$39.6M
Q3 25
$43.4M
Q2 25
$71.0M
$43.4M
Q1 25
$47.3M
Q4 24
$44.4M
Q3 24
$53.1M
Q2 24
$71.1M
$53.1M
Q1 24
$54.8M
Net Profit
CHR
CHR
SBC
SBC
Q4 25
$14.2M
Q3 25
$12.8M
Q2 25
$7.8M
$2.5M
Q1 25
$21.5M
Q4 24
$6.5M
Q3 24
$2.8M
Q2 24
$12.4M
$18.5M
Q1 24
$18.8M
Gross Margin
CHR
CHR
SBC
SBC
Q4 25
73.1%
Q3 25
70.6%
Q2 25
70.7%
69.2%
Q1 25
79.7%
Q4 24
76.3%
Q3 24
81.5%
Q2 24
73.4%
74.2%
Q1 24
72.1%
Operating Margin
CHR
CHR
SBC
SBC
Q4 25
32.5%
Q3 25
36.6%
Q2 25
11.7%
33.6%
Q1 25
51.1%
Q4 24
10.6%
Q3 24
26.1%
Q2 24
16.4%
51.4%
Q1 24
44.6%
Net Margin
CHR
CHR
SBC
SBC
Q4 25
35.9%
Q3 25
29.6%
Q2 25
10.9%
5.7%
Q1 25
45.4%
Q4 24
14.7%
Q3 24
5.3%
Q2 24
17.5%
34.8%
Q1 24
34.2%
EPS (diluted)
CHR
CHR
SBC
SBC
Q4 25
$0.15
Q3 25
$0.12
Q2 25
$0.67
$0.02
Q1 25
$0.21
Q4 24
$0.05
Q3 24
$0.03
Q2 24
$1.23
$0.20
Q1 24
$0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHR
CHR
SBC
SBC
Cash + ST InvestmentsLiquidity on hand
$164.1M
Total DebtLower is stronger
$42.8M
Stockholders' EquityBook value
$322.1M
$248.3M
Total Assets
$362.7M
$380.4M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHR
CHR
SBC
SBC
Q4 25
$164.1M
Q3 25
$127.4M
Q2 25
$152.7M
Q1 25
$132.1M
Q4 24
$125.0M
Q3 24
$137.4M
Q2 24
$186.1M
Q1 24
Total Debt
CHR
CHR
SBC
SBC
Q4 25
$42.8M
Q3 25
$21.1M
Q2 25
$7.1M
Q1 25
$6.9M
Q4 24
$6.6M
Q3 24
$823.2K
Q2 24
Q1 24
Stockholders' Equity
CHR
CHR
SBC
SBC
Q4 25
$248.3M
Q3 25
$248.0M
Q2 25
$322.1M
$244.6M
Q1 25
$226.4M
Q4 24
$195.1M
Q3 24
$205.0M
Q2 24
$286.1M
$8.8M
Q1 24
$9.0M
Total Assets
CHR
CHR
SBC
SBC
Q4 25
$380.4M
Q3 25
$321.4M
Q2 25
$362.7M
$315.3M
Q1 25
$284.6M
Q4 24
$266.1M
Q3 24
$296.5M
Q2 24
$333.2M
$19.5M
Q1 24
$19.8M
Debt / Equity
CHR
CHR
SBC
SBC
Q4 25
0.17×
Q3 25
0.09×
Q2 25
0.03×
Q1 25
0.03×
Q4 24
0.03×
Q3 24
0.00×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHR
CHR
SBC
SBC
Operating Cash FlowLast quarter
$3.9M
$52.0M
Free Cash FlowOCF − Capex
$51.2M
FCF MarginFCF / Revenue
129.3%
Capex IntensityCapex / Revenue
2.0%
Cash ConversionOCF / Net Profit
0.51×
3.66×
TTM Free Cash FlowTrailing 4 quarters
$23.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHR
CHR
SBC
SBC
Q4 25
$52.0M
Q3 25
$-20.9M
Q2 25
$3.9M
$-8.3M
Q1 25
$1.9M
Q4 24
$-7.3M
Q3 24
$5.0M
Q2 24
$-6.7M
$19.2M
Q1 24
$3.7M
Free Cash Flow
CHR
CHR
SBC
SBC
Q4 25
$51.2M
Q3 25
$-20.9M
Q2 25
$-8.6M
Q1 25
$1.7M
Q4 24
$-7.9M
Q3 24
$4.6M
Q2 24
$18.3M
Q1 24
$3.0M
FCF Margin
CHR
CHR
SBC
SBC
Q4 25
129.3%
Q3 25
-48.3%
Q2 25
-19.9%
Q1 25
3.5%
Q4 24
-17.8%
Q3 24
8.7%
Q2 24
34.5%
Q1 24
5.4%
Capex Intensity
CHR
CHR
SBC
SBC
Q4 25
2.0%
Q3 25
0.1%
Q2 25
0.7%
Q1 25
0.5%
Q4 24
1.3%
Q3 24
0.8%
Q2 24
1.6%
Q1 24
1.3%
Cash Conversion
CHR
CHR
SBC
SBC
Q4 25
3.66×
Q3 25
-1.63×
Q2 25
0.51×
-3.39×
Q1 25
0.09×
Q4 24
-1.12×
Q3 24
1.77×
Q2 24
-0.54×
1.04×
Q1 24
0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CHR
CHR

Segment breakdown not available.

SBC
SBC

Franchising$10.3M26%
Medical Corporation Shobikai$8.1M21%
Medical Corporation Nasukai$7.2M18%
Management Services$6.3M16%
Rental Services$4.3M11%
Medical Corporation Association Furinkai$3.0M8%
Japan Medical And Beauty Inc$656.5K2%

Related Comparisons